Remarkably, a recent paper has described the existence of a subpopulation of endothelial cells within GBM, harboring a CSC phenotype (CD133+/CD144−) and with the ability to differentiate into tumor and endothelial lineages, possibly via an intermediate CD133+/CD144+ progenitor cell [102]. This evidence concerns the gene CDH5 and glioblastoma.